Literature DB >> 15342212

Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial.

Karen Woods1, James D Douketis, Terri Schnurr, Krystyna Kinnon, Peter Powers, Mark A Crowther.   

Abstract

BACKGROUND: Patients who are receiving warfarin therapy require frequent blood testing to monitor the intensity of anticoagulation. Although previous studies suggest that capillary blood monitoring of the international normalize ratio (INR) is rapid and reliable, patient preferences for the method of blood drawing have not been investigated.
METHODS: We performed a randomized controlled trial of patients attending an anticoagulation clinic in which patients were randomly allocated to undergo capillary or venous INR monitoring. Patient satisfaction with the outpatient visit, pain associated with blood drawing, and time spent in the clinic were assessed for each patient.
RESULTS: Sixty patients were studied. Using a 10-point visual analogue scale to quantify patient satisfaction (0-very satisfied; 10-very dissatisfied), patients expressed a strong preference for capillary INR monitoring over venous INR monitoring (1.64 vs. 4.45; P < 0.001). Using a 10-point visual analogue scale to quantify pain with blood sampling (0-no pain; 10-very painful), patients who underwent capillary INR testing had less pain than venous INR testing (0.83 vs. 2.23; P < or = 0.004). Patients spent, on average, 33 fewer minutes in the clinic with capillary INR testing than venous INR testing (P < 0.001). DISCUSSION: Our findings support the routine use of capillary blood testing, using a portable monitor, for the management of patients in outpatient anticoagulation clinics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342212     DOI: 10.1016/j.thromres.2004.05.013

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry.

Authors:  Andrew G Chambers; Andrew J Percy; Juncong Yang; Alexander G Camenzind; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2012-12-07       Impact factor: 5.911

2.  The feasibility of fingerstick blood collection for point-of-care HIV-1 viral load monitoring in rural Zambia.

Authors:  Catherine G Sutcliffe; Kara M Palamountain; Sylvia Maunga; Kelly M Searle; Philip E Thuma; William J Moss; Mark J Fisher
Journal:  Glob Health Innov       Date:  2018-11-28

3.  Clozapine blood level assessment using a point-of-care device: feasibility and reliability.

Authors:  Shiri Kamhi-Nesher; Sharon Taub; Shikma Halimi; Maria Frenkel; Mahmud Azam; Gil Bormant; Helena Isakov; Dikla Radzinsky; Abraham Weizman; Amir Krivoy
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-14

4.  Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis.

Authors:  Nicholas J A Webb; Malcolm G Coulthard; Richard S Trompeter; Margaret M Fitzpatrick; Suzanne Stephens; Jan Dudley; Heather Maxwell; Simon Waller; Graham C Smith; Alan R Watson; David A Hughes; Brian G Keevil; Janice S Ellis
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

5.  Improving anticoagulation therapy using point-of-care testing and a standardized protocol.

Authors:  Curtis A Franke; Lori M Dickerson; Peter J Carek
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

6.  Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

7.  Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Authors:  Bart Remmerie; Marc De Meulder; Jay Ariyawansa; Adam Savitz
Journal:  Clin Pharmacol Drug Dev       Date:  2016-08-17

8.  Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Authors:  Bart Remmerie; Marc De Meulder; Sveta Weiner; Adam Savitz
Journal:  Clin Pharmacol Drug Dev       Date:  2016-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.